SCHEMBL6743069

SCHEMBL6743069

O=C(O)NN=C1c2cc(S(=O)(=O)Nc3cccc(O)c3)ccc2-c2ccc(S(=O)(=O)Nc3cccc(O)c3)cc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B2 P37059 3/20 0.52
KMT2A Q03164 4/20 0.52
PKM P14618 2/20 0.50
UQCRB P14927 1/20 0.49
MAPT P10636 3/20 0.48
POLB P06746 3/20 0.48
MEN1 O00255 3/20 0.45
HTT P42858 2/20 0.45
MAPK1 P28482 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
GAA P10253 1/20 0.44
STAT3 P40763 1/20 0.44
KDR P35968 3/20 0.43
AURKB Q96GD4 3/20 0.43
AURKA O14965 1/20 0.43
MAP4K4 O95819 1/20 0.43
PAK4 O96013 1/20 0.43
PIM1 P11309 1/20 0.43
LTK P29376 1/20 0.43
MAPK14 Q16539 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6701816 0.85 HSD17B2 (0.54) HSD17B2KMT2APKMUQCRBMAPT
SCHEMBL6702193 0.84 UQCRB (0.51) HSD17B2KMT2APKMUQCRBMAPT
SCHEMBL6704050 0.84 AURKB (0.59) HSD17B2KMT2APKMUQCRBMAPT
SCHEMBL6702181 0.84 HSD17B2 (0.58) HSD17B2KMT2APKMUQCRBMAPT
SCHEMBL6703748 0.81 AURKB (0.59) HSD17B2KMT2APKMUQCRBMAPT
SCHEMBL6703746 0.81 AURKB (0.59) HSD17B2KMT2APKMUQCRBMAPT
SCHEMBL6704528 0.81 AURKB (0.59) HSD17B2KMT2APKMUQCRBMAPT
SCHEMBL6703763 0.81 STAT3 (0.65) HSD17B2KMT2APKMUQCRBMAPT
SCHEMBL6700596 0.80 KMT2A (0.48) HSD17B2KMT2APKMUQCRBMAPT
SCHEMBL6699364 0.78 HSD17B2 (0.54) HSD17B2KMT2APKMUQCRBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6693136-B1 DISULFONAMIDE DERIVATIVES; PAIN, URINARY INCONTINENCE, BLADDER OVERACTIVITY ABBOTT LABORATORIES 2004-02-17 US disclosed